Voluntary Control of Drug Promotion in Sweden
E Perman
Abstract
E Perman
Abstract
Ethical aspects of the interaction between doctors and the pharmaceutical industry are often discussed in the Journal,1 2 3 and the suggestion was recently made that a commission be established to develop guidelines for ethical behavior.2 Sweden has had a voluntary commission of this type for more than 20 years. The commission sets guidelines for the marketing activities of pharmaceutical companies and monitors their adherence to these guidelines.The initiative came from the pharmaceutical industry itself. Almost all pharmaceutical companies in Sweden are members of either the Association of the Swedish Pharmaceutical Industry or the Association of Representatives of Foreign Pharmaceutical . . .
OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ethical aspects of the interaction between doctors and the pharmaceutical industry are often discussed in the Journal,1 2 3 and the suggestion was recently made that a commission be established to develop guidelines for ethical behavior.2 Sweden has had a voluntary commission of this type for more than 20 years. The commission sets guidelines for the marketing activities of pharmaceutical companies and monitors their adherence to these guidelines.The initiative came from the pharmaceutical industry itself. Almost all pharmaceutical companies in Sweden are members of either the Association of the Swedish Pharmaceutical Industry or the Association of Representatives of Foreign Pharmaceutical . . .
Key concepts: Pharmaceutical industry, Commission, Medicine, Promotion (chess), Drug industry, Control (management), Conflict of interest, Pharmaceutical marketing